Wednesday, December 2 | 3:00 p.m.–4:00 p.m. | W7-SSIR03-5 | Room E353A
Genicular artery embolization (GAE) reduced pain and improved function in patients with symptomatic knee osteoarthritis, with improvements sustained through six months, according to research in this session.
In the RAMBO registry, a prospective study enrolling 95 consecutive patients (124 knees), investigators assessed clinical response using OMERACT-OARSI responder criteria, a composite validated threshold for meaningful improvement in osteoarthritis, noted presenter Nick Prus, a second-year medical student at the University of Illinois College of Medicine in Chicago.
Technical success was 100%, with an average of 3.20 vessels treated per procedure. At one month, WOMAC total scores fell 37.27% and VAS pain scores 29.35%, with an OMERACT-OARSI responder rate of 67.07%. By three months, the responder rate climbed to 72.88%, with WOMAC pain scores down 37.40%. At six months follow-up (n = 33 knees) WOMAC total scores had declined 31.47%, WOMAC pain scores 40.16%, and VAS scores 35.42%, with a responder rate of 69.70%. All adverse events were access-site related and resolved by one month; no infections, osteonecrosis, nerve injury, or major vascular complications occurred.
The registry was designed to prospectively evaluate GAE in patients who had failed conservative management and were not yet candidates for or wished to delay total knee arthroplasty, the authors noted, reinforcing its role as a minimally invasive bridge between conservative care and surgery for chronic knee pain.
“In this prospective registry, GAE was associated with improvements in patient-reported outcomes. These findings represent interim results. Continued longitudinal follow-up and expanded sample size will be necessary to further evaluate response durability,” the authors concluded.
Stop by this interventional radiology scientific session for all the details.



